WEDNESDAY, DECEMBER 11 BREAKOUT SESSION

---

Converging Biology of Neuroendocrine Differentiation in Lung and Prostate Cancer

Triparna Sen, PhD

Exploring The Utility of The Epigenome in Advanced Prostate Cancer 

Amina Zoubeidi, MSc, PhD

Learning Tumor Biology from Prostate Spatial Transcriptomics Analysis

Alfonso Urbanucci, PhD

Germline Testing/Management of Patients with DNA Damage Repair Mutations

Todd Morgan, MD

Can the Molecular Landscape Define the Clinical Management of Patients with Advanced Prostate Cancer?

Natasha Kyprianou, MBBS, PhD

Status of Genomic Testing in CRPC

William Oh, MD

Q&A

Defining the Biology and Molecular Insights of Low-PSA Invisible Prostate Cancer to Develop a Therapeutic Paradigm

Goutam Chakraborty, PhD

Atypical Intraductal Proliferations of the Prostate

Samson Fine, MD

Positive Surgical Margins in the Context of NeuroSAFE Radical Prostatectomies: Which Margins Matter?

Swati Bhardwaj, MBBS, MD

Extracellular Vesicles: Liquid Biopsies for Prostate Cancer Detection

Navneet Dogra, PhD

Q&A

Neoantigen Cancer Vaccines

Nina Bhardwaj, MD, PhD

Novel Immunotherapy Approaches for Prostate Cancer

Susan Slovin, MD, PhD

ABI1 as Homeostatic Gene Controlling EMT and Androgen Signaling in Prostate Cancer

Leszek Kotula, MD, PhD

Prostate Cancer Vaccine Trials

Sujit Nair, PhD

(Non-CME)

Exosome-Based Urine Biomarkers for Prostate Cancer

Johan Skog, PhD

Return to Main Session / Break